Cognetivity Neurosciences Ltd.
CGNSF · OTC
10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
|---|---|---|---|---|
| Revenue | $29 | $20 | $4 | $45 |
| % Growth | 43.7% | 387% | -90.8% | – |
| Cost of Goods Sold | $480 | $8 | $7 | $5 |
| Gross Profit | -$451 | $13 | -$3 | $41 |
| % Margin | -1,547.3% | 62.5% | -64.5% | 89.3% |
| R&D Expenses | $43 | $84 | $162 | -$284 |
| G&A Expenses | $846 | $757 | $871 | $1,407 |
| SG&A Expenses | $863 | $796 | $957 | $1,618 |
| Sales & Mktg Exp. | $17 | $39 | $87 | $210 |
| Other Operating Expenses | -$480 | $0 | $0 | -$115 |
| Operating Expenses | $426 | $916 | $1,139 | $1,437 |
| Operating Income | -$877 | -$895 | -$1,134 | -$1,510 |
| % Margin | -3,009.4% | -4,414.5% | -27,233.5% | -3,327.9% |
| Other Income/Exp. Net | -$1,159 | -$1,069 | -$989 | -$515 |
| Pre-Tax Income | -$2,037 | -$1,935 | -$2,107 | -$2,564 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,037 | -$1,935 | -$2,107 | -$2,564 |
| % Margin | -6,985.2% | -9,538.9% | -50,592.6% | -5,652.4% |
| EPS | -0.023 | -0.022 | -0.025 | -0.03 |
| % Growth | -3.6% | 9.8% | 18.5% | – |
| EPS Diluted | -0.023 | -0.022 | -0.025 | -0.03 |
| Weighted Avg Shares Out | 88,369 | 87,082 | 85,662 | 85,049 |
| Weighted Avg Shares Out Dil | 88,369 | 87,082 | 85,662 | 85,049 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,329 | $1,176 | $1,131 | $915 |
| Depreciation & Amortization | $7 | $8 | $7 | $5 |
| EBITDA | -$700 | -$751 | -$969 | -$1,505 |
| % Margin | -2,401.9% | -3,703.9% | -23,270.9% | -3,317.2% |